Insomnia & Sleep Disorders
About This Condition
Chronic insomnia affects roughly 30% of adults and is associated with elevated risk for cardiovascular disease, diabetes, obesity, depression, cognitive decline, and all-cause mortality. It is also one of the most pharmacologically overtreated conditions in medicine — benzodiazepines and Z-drugs are prescribed reflexively despite strong evidence that cognitive behavioral therapy for insomnia (CBT-I) outperforms pharmacology in long-term outcomes and carries no dependency risk. Sleep apnea is underdiagnosed in primary care and is a significant driver of metabolic disease, hypertension, and cardiovascular events, yet it is frequently missed in non-obese patients and women.
.png)





.png)



